Effects and mechanism of organ protection by cardiotrophin-1

Current Medicinal Chemistry

Volumn 20, Issue 2, 2013, Pages 246-256

  Garcia Cenador M B ^a,b   Lopez Novoa, J M ^a   Diez J ^c,d   Garcia Criado F J ^a,b  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

^d University Clinic ^*  (Spain)

Author keywords

Cardiotrophin 1; Cytokines; Cytoprotection; Gp130; Heart; IL 6; JAK; LIF receptor; Liver; SOCS; STAT

Indexed keywords

CARDIOTROPHIN 1; GLYCOPROTEIN GP 130; JANUS KINASE; LEUKEMIA INHIBITORY FACTOR RECEPTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR BETA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P42; PROTEIN P44; STAT PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL PROTECTION; ENERGY METABOLISM; HOMEOSTASIS; HUMAN; INFLAMMATION; LIVER PROTECTION; MOLECULAR MECHANICS; NEUROPROTECTION; OXIDATIVE STRESS; RENAL PROTECTION; SIGNAL TRANSDUCTION;

EID: 84877945407     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986713804806702     Document Type: Article

References (157)

1. Pennica, D.; King, K.L.; Shaw, K.J.; Luis, E.; Rullamas, J.; Luoh, S.M.; Darbonne, W.C.; Knutzon, D.S.; Yen, R.; Chien, K.R.;et al. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc. Natl. Acad. Sci. U S A., 1995, 92, 1142-1146.
2. Kishimoto, T.; Akira, S.; Narazaki, M.;Taga, T. Interleukin-6 family of cytokines and gp130. Blood, 1995, 86, 1243-1254.
3. Huising, M.O.; Kruiswijk, C.P.;Flik, G. Phylogeny and evolution of class-I helical cytokines. J. Endocrinol., 2006, 189, 1-25. (Pubitemid 43670697)
4. Heinrich, P.C.; Behrmann, I.; Haan, S.; Hermanns, H.M.; Muller-Newen, G.;Schaper, F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J., 2003, 374, 1-20. (Pubitemid 37046923)
5. Pflanz, S.; Timans, J.C.; Cheung, J.; Rosales, R.; Kanzler, H.; Gilbert, J.; Hibbert, L.; Churakova, T.; Travis, M.; Vaisberg, E.; Blumenschein, W.M.; Mattson, J.D.; Wagner, J.L.; To, W.; Zurawski, S.; McClanahan, T.K.; Gorman, D.M.; Bazan, J.F.; de Waal Malefyt, R.; Rennick, D.;Kastelein, R.A. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity, 2002, 16, 779-790. (Pubitemid 34786477)
6. Trinchieri, G.; Pflanz, S.;Kastelein, R.A. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity, 2003, 19, 641-644. (Pubitemid 37490789)
7. Dillon, S.R.; Sprecher, C.; Hammond, A.; Bilsborough, J.; Rosenfeld-Franklin, M.; Presnell, S.R.; Haugen, H.S.; Maurer, M.; Harder, B.; Johnston, J.; Bort, S.; Mudri, S.; Kuijper, J.L.; Bukowski, T.; Shea, P.; Dong, D.L.; Dasovich, M.; Grant, F.J.; Lockwood, L.; Levin, S.D.; LeCiel, C.; Waggie, K.; Day, H.; Topouzis, S.; Kramer, J.; Kuestner, R.; Chen, Z.; Foster, D.; Parrish-Novak, J.;Gross, J.A. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat. Immunol., 2004, 5, 752-760. (Pubitemid 39023308)
8. Elson, G.C.; Lelievre, E.; Guillet, C.; Chevalier, S.; Plun-Favreau, H.; Froger, J.; Suard, I.; de Coignac, A.B.; Delneste, Y.; Bonnefoy, J.Y.; Gauchat, J.F.;Gascan, H. CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex. Nat. Neurosci., 2000, 3, 867-872.
9. Taga, T.;Kishimoto, T. Gp130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol., 1997, 15, 797-819. (Pubitemid 27169299)
10. Derouet, D.; Rousseau, F.; Alfonsi, F.; Froger, J.; Hermann, J.; Barbier, F.; Perret, D.; Diveu, C.; Guillet, C.; Preisser, L.; Dumont, A.; Barbado, M.; Morel, A.; deLapeyriere, O.; Gascan, H.;Chevalier, S. Neuropoietin, a new IL-6-related cytokine signaling through the ciliary neurotrophic factor receptor. Proc. Natl. Acad. Sci. U S A., 2004, 101, 4827-4832. (Pubitemid 38469162)
11. Pennica, D.; Arce, V.; Swanson, T.A.; Vejsada, R.; Pollock, R.A.; Armanini, M.; Dudley, K.; Phillips, H.S.; Rosenthal, A.; Kato, A.C.;Henderson, C.E. Cardiotrophin-1, a cytokine present in embryonic muscle, supports long-term survival of spinal motoneurons. Neuron., 1996, 17, 63-74. (Pubitemid 26251592)
12. Erdmann, J.; Hassfeld, S.; Kallisch, H.; Fleck, E.;Regitz-Zagrosek, V. Cloning and characterization of the 5'-flanking region of the human cardiotrophin-1 gene. Biochem. Biophys. Res. Commun., 1998, 244, 494-497. (Pubitemid 28414110)
13. Pennica, D.; Swanson, T.A.; Shaw, K.J.; Kuang, W.J.; Gray, C.L.; Beatty, B.G.;Wood, W.I. Human cardiotrophin-1: protein and gene structure, biological and binding activities, and chromosomal localization. Cytokine, 1996, 8, 183-189. (Pubitemid 26111115)
14. Sheng, Z.; Pennica, D.; Wood, W.I.;Chien, K.R. Cardiotrophin-1 displays early expression in the murine heart tube and promotes cardiac myocyte survival. Development, 1996, 122, 419-428. (Pubitemid 26056393)
15. Ishikawa, M.; Saito, Y.; Miyamoto, Y.; Kuwahara, K.; Ogawa, E.; Nakagawa, O.; Harada, M.; Masuda, I.;Nakao, K. cDNA cloning of rat cardiotrophin-1 (CT-1): augmented expression of CT-1 gene in ventricle of genetically hypertensive rats. Biochem. Biophys. Res. Commun., 1996, 219, 377-381. (Pubitemid 26090907)
16. Pennica, D.; Wood, W.I.;Chien, K.R. Cardiotrophin-1: a multifunctional cytokine that signals via LIF receptor-gp 130 dependent pathways. Cytokine Growth Factor Rev., 1996, 7, 81-91. (Pubitemid 27202667)
17. Natal, C.; Fortuno, M.A.; Restituto, P.; Bazan, A.; Colina, I.; Diez, J.;Varo, N. Cardiotrophin-1 is expressed in adipose tissue and upregulated in the metabolic syndrome. Am. J. Physiol. Endocrinol. Metab., 2008, 294, E52-60.
18. Fukuzawa, J.; Booz, G.W.; Hunt, R.A.; Shimizu, N.; Karoor, V.; Baker, K.M.;Dostal, D.E. Cardiotrophin-1 increases angiotensinogen mRNA in rat cardiac myocytes through STAT3 : an autocrine loop for hypertrophy. Hypertension, 2000, 35, 1191-1196. (Pubitemid 30413649)
19. Lopez-Andres, N.; Inigo, C.; Gallego, I.; Diez, J.;Fortuno, M.A. Aldosterone induces cardiotrophin-1 expression in HL-1 adult cardiomyocytes. Endocrinology, 2008, 149, 4970-4978.
20. Funamoto, M.; Hishinuma, S.; Fujio, Y.; Matsuda, Y.; Kunisada, K.; Oh, H.; Negoro, S.; Tone, E.; Kishimoto, T.;Yamauchi-Takihara, K. Isolation and characterization of the murine cardiotrophin-1 gene: expression and norepinephrine-induced transcriptional activation. J. Mol. Cell. Cardiol., 2000, 32, 1275-1284.
21. Janjua, S.; Lawrence, K.M.; Ng, L.L.;Latchman, D.S. The cardioprotective agent urocortin induces expression of CT-1. Cardiovasc. Toxicol., 2003, 3, 255-262.
22. Jiang, Z.S.; Jeyaraman, M.; Wen, G.B.; Fandrich, R.R.; Dixon, I.M.; Cattini, P.A.;Kardami, E. High-but not low-molecular weight FGF-2 causes cardiac hypertrophy in vivo; possible involvement of cardiotrophin-1. J. Mol. Cell. Cardiol., 2007, 42, 222-233. (Pubitemid 44958615)
23. Pan, J.; Fukuda, K.; Saito, M.; Matsuzaki, J.; Kodama, H.; Sano, M.; Takahashi, T.; Kato, T.;Ogawa, S. Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes. Circ. Res., 1999, 84, 1127-1136. (Pubitemid 29244774)
24. Liu, J.; Liu, Z.; Huang, F.; Xing, Z.; Wang, H.;Li, Z. Pioglitazone inhibits hypertrophy induced by high glucose and insulin in cultured neonatal rat cardiomyocytes. Pharmazie, 2007, 62, 925-929. (Pubitemid 350305769)
25. Hishinuma, S.; Funamoto, M.; Fujio, Y.; Kunisada, K.;Yamauchi-Takihara, K. Hypoxic stress induces cardiotrophin-1 expression in cardiac myocytes. Biochem. Biophys. Res. Commun., 1999, 264, 436-440. (Pubitemid 29516105)
26. Robador, P.A.; San Jose, G.; Rodriguez, C.; Guadall, A.; Moreno, M.U.; Beaumont, J.; Fortuno, A.; Diez, J.; Martinez-Gonzalez, J.;Zalba, G. HIF-1-mediated up-regulation of cardiotrophin-1 is involved in the survival response of cardiomyocytes to hypoxia. Cardiovasc. Res., 2011, 92, 247-255.
27. Latchman, D.S. Cardiotrophin-1: a novel cytokine and its effects in the heart and other tissues. Pharmacol. Ther., 2000, 85, 29-37.
28. Silver, J.S.;Hunter, C.A. gp130 at the nexus of inflammation, autoimmunity, and cancer. J. Leukoc. Biol., 2010, 88, 1145-1156.
29. Sims, N.A.;Walsh, N.C. GP130 cytokines and bone remodelling in health and disease. BMB. Rep., 2010, 43, 513-523.
30. Peters, M.; Roeb, E.; Pennica, D.; Meyer zum Buschenfelde, K.H.;Rose-John, S. A new hepatocyte stimulating factor: cardiotrophin-1 (CT-1). FEBS. Lett., 1995, 372, 177-180.
31. Bordet, T.; Lesbordes, J.C.; Rouhani, S.; Castelnau-Ptakhine, L.; Schmalbruch, H.; Haase, G.;Kahn, A. Protective effects of cardiotrophin-1 adenoviral gene transfer on neuromuscular degeneration in transgenic ALS mice. Hum. Mol. Genet., 2001, 10, 1925-1933. (Pubitemid 32910537)
32. Richards, C.D.; Langdon, C.; Deschamps, P.; Pennica, D.;Shaughnessy, S.G. Stimulation of osteoclast differentiation in vitro by mouse oncostatin M, leukaemia inhibitory factor, cardiotrophin-1 and interleukin 6: synergy with dexamethasone. Cytokine, 2000, 12, 613-621. (Pubitemid 30453489)
33. Pulido, E.J.; Shames, B.D.; Pennica, D.; O'Leary R, M.; Bensard, D.D.; Cain, B.S.;McIntyre, R.C., Jr. Cardiotrophin-1 attenuates endotoxin-induced acute lung injury. J. Surg. Res., 1999, 84, 240-246. (Pubitemid 29390004)
34. Lopez-Andres, N.; Rousseau, A.; Akhtar, R.; Calvier, L.; Inigo, C.; Labat, C.; Zhao, X.; Cruickshank, K.; Diez, J.; Zannad, F.; Lacolley, P.;Rossignol, P. Cardiotrophin 1 is involved in cardiac, vascular, and renal fibrosis and dysfunction. Hypertension, 2012, 60, 563-573.
35. Zolk, O.; Engmann, S.; Munzel, F.;Krajcik, R. Chronic cardiotrophin-1 stimulation impairs contractile function in reconstituted heart tissue. Am. J. Physiol. Endocrinol. Metab., 2005, 288, E1214-1221. (Pubitemid 40726809)
36. Gonzalez, A.; Lopez, B.; Ravassa, S.; Beaumont, J.; Zudaire, A.; Gallego, I.; Brugnolaro, C.;Diez, J. Cardiotrophin-1 in hypertensive heart disease. Endocrine, 2012, 42, 9-17.
37. Calabro, P.; Limongelli, G.; Riegler, L.; Maddaloni, V.; Palmieri, R.; Golia, E.; Roselli, T.; Masarone, D.; Pacileo, G.; Golino, P.;Calabro, R. Novel insights into the role of cardiotrophin-1 in cardiovascular diseases. J. Mol. Cell. Cardiol., 2009, 46, 142-148.
38. Wollert, K.C.; Taga, T.; Saito, M.; Narazaki, M.; Kishimoto, T.; Glembotski, C.C.; Vernallis, A.B.; Heath, J.K.; Pennica, D.; Wood, W.I.;Chien, K.R. Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series VIA gp130/leukemia inhibitory factor receptor-dependent pathways. J. Biol. Chem., 1996, 271, 9535-9545.
39. Robledo, O.; Fourcin, M.; Chevalier, S.; Guillet, C.; Auguste, P.; Pouplard-Barthelaix, A.; Pennica, D.;Gascan, H. Signaling of the cardiotrophin-1 receptor. Evidence for a third receptor component. J. Biol. Chem., 1997, 272, 4855-4863. (Pubitemid 27090033)
40. Pennica, D.; Shaw, K.J.; Swanson, T.A.; Moore, M.W.; Shelton, D.L.; Zioncheck, K.A.; Rosenthal, A.; Taga, T.; Paoni, N.F.;Wood, W.I. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J. Biol. Chem., 1995, 270, 10915-10922.
41. Yoshida, K.; Taga, T.; Saito, M.; Suematsu, S.; Kumanogoh, A.; Tanaka, T.; Fujiwara, H.; Hirata, M.; Yamagami, T.; Nakahata, T.; Hirabayashi, T.; Yoneda, Y.; Tanaka, K.; Wang, W.Z.; Mori, C.; Shiota, K.; Yoshida, N.;Kishimoto, T. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc. Natl. Acad. Sci. U S A., 1996, 93, 407-411. (Pubitemid 26041485)
42. Yamauchi-Takihara, K.;Kishimoto, T. Cytokines and their receptors in cardiovascular diseases-role of gp130 signalling pathway in cardiac myocyte growth and maintenance. Int. J. Exp. Pathol., 2000, 81, 1-16. (Pubitemid 30171497)
43. Fischer, P.;Hilfiker-Kleiner, D. Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis. Basic. Res. Cardiol., 2007, 102, 279-297. (Pubitemid 46909707)
44. Ernst, M.;Jenkins, B.J. Acquiring signalling specificity from the cytokine receptor gp130. Trends. Genet., 2004, 20, 23-32. (Pubitemid 38032817)
45. Kumar, G.; Gupta, S.; Wang, S.;Nel, A.E. Involvement of Janus kinases, p52shc, Raf-1, and MEK-1 in the IL-6-induced mitogen-Activated protein kinase cascade of a growth-responsive B cell line. J. Immunol., 1994, 153, 4436-4447.
46. Nakafuku, M.; Satoh, T.;Kaziro, Y. Differentiation factors, including nerve growth factor, fibroblast growth factor, and interleukin-6, induce an accumulation of an active Ras.GTP complex in rat pheochromocytoma PC12 cells. J. Biol. Chem., 1992, 267, 19448-19454.
47. Boulton, T.G.; Stahl, N.;Yancopoulos, G.D. Ciliary neurotrophic factor/leukemia inhibitory factor/interleukin 6/oncostatin M family of cytokines induces tyrosine phosphorylation of a common set of proteins overlapping those induced by other cytokines and growth factors. J. Biol. Chem., 1994, 269, 11648-11655.
48. Stahl, N.; Farruggella, T.J.; Boulton, T.G.; Zhong, Z.; Darnell, J.E., Jr.;Yancopoulos, G.D. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science, 1995, 267, 1349-1353.
49. Takahashi-Tezuka, M.; Yoshida, Y.; Fukada, T.; Ohtani, T.; Yamanaka, Y.; Nishida, K.; Nakajima, K.; Hibi, M.;Hirano, T. Gab1 acts as an adapter molecule linking the cytokine receptor gp130 to ERK mitogen-Activated protein kinase. Mol. Cell. Biol., 1998, 18, 4109-4117. (Pubitemid 28287934)
50. Febbraio, M.A. gp130 receptor ligands as potential therapeutic targets for obesity. J. Clin. Invest., 2007, 117, 841-849. (Pubitemid 46556736)
51. Takahashi, Y.; Carpino, N.; Cross, J.C.; Torres, M.; Parganas, E.;Ihle, J.N. SOCS3: an essential regulator of LIF receptor signaling in trophoblast giant cell differentiation. EMBO. J., 2003, 22, 372-384. (Pubitemid 36193583)
52. Starr, R.; Willson, T.A.; Viney, E.M.; Murray, L.J.; Rayner, J.R.; Jenkins, B.J.; Gonda, T.J.; Alexander, W.S.; Metcalf, D.; Nicola, N.A.;Hilton, D.J. A family of cytokine-inducible inhibitors of signalling. Nature, 1997, 387, 917-921. (Pubitemid 27289594)
53. Hamanaka, I.; Saito, Y.; Yasukawa, H.; Kishimoto, I.; Kuwahara, K.; Miyamoto, Y.; Harada, M.; Ogawa, E.; Kajiyama, N.; Takahashi, N.; Izumi, T.; Kawakami, R.; Masuda, I.; Yoshimura, A.;Nakao, K. Induction of JAB/SOCS-1/SSI-1 and CIS3/SOCS-3/SSI-3 is involved in gp130 resistance in cardiovascular system in rat treated with cardiotrophin-1 in vivo. Circ. Res., 2001, 88, 727-732. (Pubitemid 32378143)
54. Symes, A.; Stahl, N.; Reeves, S.A.; Farruggella, T.; Servidei, T.; Gearan, T.; Yancopoulos, G.;Fink, J.S. The protein tyrosine phosphatase SHP-2 negatively regulates ciliary neurotrophic factor induction of gene expression. Curr. Biol., 1997, 7, 697-700. (Pubitemid 27408869)
55. Lehmann, U.; Schmitz, J.; Weissenbach, M.; Sobota, R.M.; Hortner, M.; Friederichs, K.; Behrmann, I.; Tsiaris, W.; Sasaki, A.; Schneider-Mergener, J.; Yoshimura, A.; Neel, B.G.; Heinrich, P.C.;Schaper, F. SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130. J. Biol. Chem., 2003, 278, 661-671. (Pubitemid 36043620)
56. Clahsen, T.; Lehmann, U.; Stross, C.; Hermanns, H.M.; Volkmer-Engert, R.; Schneider-Mergener, J.; Heinrich, P.C.;Schaper, F. The tyrosine 974 within the LIF-R-chain of the gp130/LIF-R heteromeric receptor complex mediates negative regulation of LIF signalling. Cell. Signal., 2005, 17, 559-569. (Pubitemid 40430959)
57. Terstegen, L.; Gatsios, P.; Bode, J.G.; Schaper, F.; Heinrich, P.C.;Graeve, L. The inhibition of interleukin-6-dependent STAT activation by mitogenactivated protein kinases depends on tyrosine 759 in the cytoplasmic tail of glycoprotein 130. J. Biol. Chem., 2000, 275, 18810-18817. (Pubitemid 30422842)
58. Jougasaki, M. Cardiotrophin-1 in cardiovascular regulation. Adv. Clin. Chem., 2010, 52, 41-76.
59. Aoyama, T.; Takimoto, Y.; Pennica, D.; Inoue, R.; Shinoda, E.; Hattori, R.; Yui, Y.;Sasayama, S. Augmented expression of cardiotrophin-1 and its receptor component, gp130, in both left and right ventricles after myocardial infarction in the rat. J. Mol. Cell. Cardiol., 2000, 32, 1821-1830.
60. Ateghang, B.; Wartenberg, M.; Gassmann, M.;Sauer, H. Regulation of cardiotrophin-1 expression in mouse embryonic stem cells by HIF-1alpha and intracellular reactive oxygen species. J. Cell. Sci., 2006, 119, 1043-1052.
61. Freed, D.H.; Moon, M.C.; Borowiec, A.M.; Jones, S.C.; Zahradka, P.;Dixon, I.M. Cardiotrophin-1: expression in experimental myocardial infarction and potential role in post-MI wound healing. Mol. Cell. Biochem., 2003, 254, 247-256. (Pubitemid 37483760)
62. Talwar, S.; Squire, I.B.; O'Brien R, J.; Downie, P.F.; Davies, J.E.;Ng, L.L. Plasma cardiotrophin-1 following acute myocardial infarction: relationship with left ventricular systolic dysfunction. Clin. Sci. (Lond), 2002, 102, 9-14. (Pubitemid 34177795)
63. Ghosh, S.; Ng, L.L.; Talwar, S.; Squire, I.B.;Galinanes, M. Cardiotrophin-1 protects the human myocardium from ischemic injury. Comparison with the first and second window of protection by ischemic preconditioning. Cardiovasc. Res., 2000, 48, 440-447.
64. Ruixing, Y.; Jinzhen, W.; Dezhai, Y.;Jiaquan, L. Cardioprotective role of cardiotrophin-1 gene transfer in a murine model of myocardial infarction. Growth Factors, 2007, 25, 286-294.
65. Brar, B.K.; Stephanou, A.; Liao, Z.; O'Leary, R.M.; Pennica, D.; Yellon, D.M.;Latchman, D.S. Cardiotrophin-1 can protect cardiac myocytes from injury when added both prior to simulated ischaemia and at reoxygenation. Cardiovasc. Res., 2001, 51, 265-274. (Pubitemid 32695537)
66. Gritman, K.; Van Winkle, D.M.; Lorentz, C.U.; Pennica, D.;Habecker, B.A. The lack of cardiotrophin-1 alters expression of interleukin-6 and leukemia inhibitory factor mRNA but does not impair cardiac injury response. Cytokine, 2006, 36, 9-16. (Pubitemid 46049014)
67. Ono, K.; Matsumori, A.; Shioi, T.; Furukawa, Y.;Sasayama, S. Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling. Circulation, 1998, 98, 149-156. (Pubitemid 28317895)
68. Marques, J.M.; Belza, I.; Holtmann, B.; Pennica, D.; Prieto, J.;Bustos, M. Cardiotrophin-1 is an essential factor in the natural defense of the liver against apoptosis. Hepatology, 2007, 45, 639-648. (Pubitemid 46450615)
69. Bustos, M.; Beraza, N.; Lasarte, J.J.; Baixeras, E.; Alzuguren, P.; Bordet, T.;Prieto, J. Protection against liver damage by cardiotrophin-1: a hepatocyte survival factor up-regulated in the regenerating liver in rats. Gastroenterology, 2003, 125, 192-201. (Pubitemid 36799119)
70. Song, J.; Zhang, Y.W.; Yao, A.H.; Yu, Y.; Hua, Z.Y.; Pu, L.Y.; Li, G.Q.; Li, X.C.; Zhang, F.; Sheng, G.Q.;Wang, X.H. Adenoviral cardiotrophin-1 transfer improves survival and early graft function after ischemia and reperfusion in rat small-for-size liver transplantation model. Transpl. Int., 2008, 21, 372-383. (Pubitemid 351348014)
71. Ho, D.W.; Yang, Z.F.; Lau, C.K.; Tam, K.H.; To, J.Y.; Poon, R.T.;Fan, S.T. Therapeutic potential of cardiotrophin 1 in fulminant hepatic failure: dual roles in antiapoptosis and cell repair. Arch. Surg., 2006, 141, 1077-1084; discussion 1084. (Pubitemid 44790533)
72. Yang, Z.F.; Lau, C.K.; Ngai, P.; Lam, S.P.; Ho, D.W.; Poon, R.T.;Fan, S.T. Cardiotrophin-1 enhances regeneration of cirrhotic liver remnant after hepatectomy through promotion of angiogenesis and cell proliferation. Liver Int., 2008, 28, 622-631. (Pubitemid 351541093)
73. Aguilar-Melero, P.; Luque, A.; Machuca, M.M.; Perez de Obanos, M.P.; Navarrete, R.; Rodriguez-Garcia, I.C.; Briceno, J.; Iniguez, M.; Ruiz, J.; Prieto, J.; de la Mata, M.; Gomez-Villamandos, R.J.; Muntane, J.;Lopez-Cillero, P. Cardiotrophin-1 reduces ischemia/reperfusion injury during liver transplant. J. Surg. Res., 2012.
74. Gard, A.L.; Gavin, E.; Solodushko, V.;Pennica, D. Cardiotrophin-1 in choroid plexus and the cerebrospinal fluid circulatory system. Neuroscience, 2004, 127, 43-52. (Pubitemid 38829150)
75. Arce, V.; Pollock, R.A.; Philippe, J.M.; Pennica, D.; Henderson, C.E.;deLapeyriere, O. Synergistic effects of schwann-And muscle-derived factors on motoneuron survival involve GDNF and cardiotrophin-1 (CT-1). J. Neurosci., 1998, 18, 1440-1448. (Pubitemid 28082429)
76. Middleton, G.; Hamanoue, M.; Enokido, Y.; Wyatt, S.; Pennica, D.; Jaffray, E.; Hay, R.T.;Davies, A.M. Cytokine-induced nuclear factor kappa B activation promotes the survival of developing neurons. J. Cell. Biol., 2000, 148, 325-332. (Pubitemid 30078244)
77. Oppenheim, R.W.; Wiese, S.; Prevette, D.; Armanini, M.; Wang, S.; Houenou, L.J.; Holtmann, B.; Gotz, R.; Pennica, D.;Sendtner, M. Cardiotrophin-1, a muscle-derived cytokine, is required for the survival of subpopulations of developing motoneurons. J. Neurosci., 2001, 21, 1283-1291. (Pubitemid 32128773)
78. Peng, H.; Sola, A.; Moore, J.;Wen, T. Caspase inhibition by cardiotrophin-1 prevents neuronal death in vivo and in vitro. J. Neurosci. Res., 2010, 88, 1041-1051.
79. Bordet, T.; Schmalbruch, H.; Pettmann, B.; Hagege, A.; Castelnau-Ptakhine, L.; Kahn, A.;Haase, G. Adenoviral cardiotrophin-1 gene transfer protects pmn mice from progressive motor neuronopathy. J. Clin. Invest., 1999, 104, 1077-1085. (Pubitemid 29536318)
80. Mitsumoto, H.; Klinkosz, B.; Pioro, E.P.; Tsuzaka, K.; Ishiyama, T.; O'Leary, R.M.;Pennica, D. Effects of cardiotrophin-1 (CT-1) in a mouse motor neuron disease. Muscle Nerve, 2001, 24, 769-777. (Pubitemid 32476523)
81. Zhang, Z.F.; Liao, W.H.; Yang, Q.F.; Li, H.Y.; Wu, Y.M.;Zhou, X.F. Protective effects of adenoviral cardiotrophin-1 gene transfer on rubrospinal neurons after spinal cord injury in adult rats. Neurotox. Res., 2003, 5, 539-548.
82. Wen, T.C.; Rogido, M.R.; Moore, J.E.; Genetta, T.; Peng, H.;Sola, A. Cardiotrophin-1 protects cortical neuronal cells against free radical-induced injuries in vitro. Neurosci. Lett., 2005, 387, 38-42. (Pubitemid 41138205)
83. Freed, D.H.; Cunnington, R.H.; Dangerfield, A.L.; Sutton, J.S.;Dixon, I.M. Emerging evidence for the role of cardiotrophin-1 in cardiac repair in the infarcted heart. Cardiovasc. Res., 2005, 65, 782-792. (Pubitemid 40249724)
84. Lopez, N.; Diez, J.;Fortuno, M.A. Characterization of the protective effects of cardiotrophin-1 against non-ischemic death stimuli in adult cardiomyocytes. Cytokine, 2005, 30, 282-292. (Pubitemid 40775848)
85. Hausenloy, D.J.;Yellon, D.M. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc. Res., 2004, 61, 448-460. (Pubitemid 38210151)
86. Havasi, A.;Borkan, S.C. Apoptosis and acute kidney injury. Kidney Int., 2011, 80, 29-40.
87. Sheng, Z.; Knowlton, K.; Chen, J.; Hoshijima, M.; Brown, J.H.;Chien, K.R. Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-Activated protein kinase-dependent pathway. Divergence from downstream CT-1 signals for myocardial cell hypertrophy. J. Biol. Chem., 1997, 272, 5783-5791. (Pubitemid 27102409)
88. Latchman, D.S. Cardiotrophin-1 (CT-1): a novel hypertrophic and cardioprotective agent. Int. J. Exp. Pathol., 1999, 80, 189-196. (Pubitemid 29469031)
89. Ruixing, Y.; Dezhai, Y.;Jiaquan, L. Effects of cardiotrophin-1 on hemodynamics and cardiomyocyte apoptosis in rats with acute myocardial infarction. J. Med. Invest., 2004, 51, 29-37.
90. Iniguez, M.; Berasain, C.; Martinez-Anso, E.; Bustos, M.; Fortes, P.; Pennica, D.; Avila, M.A.;Prieto, J. Cardiotrophin-1 defends the liver against ischemia-reperfusion injury and mediates the protective effect of ischemic preconditioning. J. Exp. Med., 2006, 203, 2809-2815. (Pubitemid 46026159)
91. Sumandea, M.P.;Steinberg, S.F. Redox signaling and cardiac sarcomeres. J. Biol. Chem., 2011, 286, 9921-9927.
92. Klune, J.R.;Tsung, A. Molecular biology of liver ischemia/reperfusion injury: established mechanisms and recent advancements. Surg. Clin. North Am., 2010, 90, 665-677.
93. Chollangi, S.; Wang, J.; Martin, A.; Quinn, J.;Ash, J.D. Preconditioninginduced protection from oxidative injury is mediated by leukemia inhibitory factor receptor (LIFR) and its ligands in the retina. Neurobiol. Dis., 2009, 34, 535-544.
94. Negoro, S.; Kunisada, K.; Fujio, Y.; Funamoto, M.; Darville, M.I.; Eizirik, D.L.; Osugi, T.; Izumi, M.; Oshima, Y.; Nakaoka, Y.; Hirota, H.; Kishimoto, T.;Yamauchi-Takihara, K. Activation of signal transducer and activator of transcription 3 protects cardiomyocytes from hypoxia/reoxygenation- induced oxidative stress through the upregulation of manganese superoxide dismutase. Circulation, 2001, 104, 979-981. (Pubitemid 32803871)
95. Jung, J.E.; Kim, G.S.;Chan, P.H. Neuroprotection by interleukin-6 is mediated by signal transducer and activator of transcription 3 and antioxidative signaling in ischemic stroke. Stroke, 2011, 42, 3574-3579.
96. Sharfuddin, A.A.;Molitoris, B.A. Pathophysiology of ischemic acute kidney injury. Nat. Rev. Nephrol., 2011, 7, 189-200.
97. Arslan, F.; de Kleijn, D.P.;Pasterkamp, G. Innate immune signaling in cardiac ischemia. Nat. Rev. Cardiol., 2011, 8, 292-300.
98. Guo, M.F.; Yu, J.Z.;Ma, C.G. Mechanisms related to neuron injury and death in cerebral hypoxic ischaemia. Folia Neuropathol., 2011, 49, 78-87.
99. Fritzenwanger, M.; Meusel, K.; Foerster, M.; Kuethe, F.; Krack, A.;Figulla, H.R. Cardiotrophin-1 induces interleukin-6 synthesis in human monocytes. Cytokine, 2007, 38, 137-144. (Pubitemid 47248297)
100. Fritzenwanger, M.; Meusel, K.; Foerster, M.; Kuethe, F.; Krack, A.;Figulla, H.R. Cardiotrophin-1 induces interleukin-6 synthesis in human umbilical vein endothelial cells. Cytokine, 2006, 36, 101-106. (Pubitemid 46275461)
101. Fritzenwanger, M.; Kuethe, F.; Haase, D.; Jandt, E.;Figulla, H.R. Cardiotrophin-1 induces monocyte chemoattractant protein-1 synthesis in human umbilical vein endothelial cells. Cytokine, 2006, 33, 46-51. (Pubitemid 43220352)
102. Ichiki, T.; Jougasaki, M.; Setoguchi, M.; Imamura, J.; Nakashima, H.; Matsuoka, T.; Sonoda, M.; Nakamura, K.; Minagoe, S.;Tei, C. Cardiotrophin-1 stimulates intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 in human aortic endothelial cells. Am. J. Physiol. Heart Circ. Physiol., 2008, 294, H750-763. (Pubitemid 351253286)
103. Craig, R.; Wagner, M.; McCardle, T.; Craig, A.G.;Glembotski, C.C. The cytoprotective effects of the glycoprotein 130 receptor-coupled cytokine, cardiotrophin-1, require activation of NF-kappa B. J. Biol. Chem., 2001, 276, 37621-37629.
104. Dolcet, X.; Soler, R.M.; Gould, T.W.; Egea, J.; Oppenheim, R.W.;Comella, J.X. Cytokines promote motoneuron survival through the Janus kinasedependent activation of the phosphatidylinositol 3-kinase pathway. Mol. Cell. Neurosci., 2001, 18, 619-631. (Pubitemid 34060144)
105. Yoshidome, H.; Kato, A.; Edwards, M.J.;Lentsch, A.B. Interleukin-10 suppresses hepatic ischemia/reperfusion injury in mice: implications of a central role for nuclear factor kappaB. Hepatology, 1999, 30, 203-208. (Pubitemid 29300587)
106. Barnes, P.J.;Karin, M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med., 1997, 336, 1066-1071. (Pubitemid 27163860)
107. Ghosh, S.;Hayden, M.S. New regulators of NF-kappaB in inflammation. Nat. Rev. Immunol., 2008, 8, 837-848.
108. Xu, S.; Zhao, Y.; Yu, L.; Shen, X.; Ding, F.;Fu, G. Rosiglitazone attenuates endothelial progenitor cell apoptosis induced by TNF-Alpha via ERK/MAPK and NF-kappaB signal pathways. J. Pharmacol. Sci., 2011, 117, 265-274.
109. Benigni, F.; Sacco, S.; Pennica, D.;Ghezzi, P. Cardiotrophin-1 inhibits tumor necrosis factor production in the heart and serum of lipopolysaccharidetreated mice and in vitro in mouse blood cells. Am. J. Pathol., 1996, 149, 1847-1850. (Pubitemid 26415206)
110. Fernandez-Ruiz, V.; Kawa, M.; Berasain, C.; Iniguez, M.; Schmitz, V.; Martinez-Anso, E.; Inarrairaegui, M.; Herrero, I.; Sangro, B.; D'Avola, D.; Quiroga, J.; Qian, C.;Prieto, J. Treatment of murine fulminant hepatitis with genetically engineered endothelial progenitor cells. J. Hepatol., 2011, 55, 828-837.
111. Wanner, G.A.; Ertel, W.; Muller, P.; Hofer, Y.; Leiderer, R.; Menger, M.D.;Messmer, K. Liver ischemia and reperfusion induces a systemic inflammatory response through Kupffer cell activation. Shock, 1996, 5, 34-40. (Pubitemid 126729531)
112. Robledo, O.; Chevalier, S.; Froger, J.; Barthelaix-Pouplard, A.; Pennica, D.;Gascan, H. Regulation of interleukin 6 expression by cardiotrophin 1. Cytokine, 1997, 9, 666-671. (Pubitemid 27399833)
113. Chen, R.H.; Chang, M.C.; Su, Y.H.; Tsai, Y.T.;Kuo, M.L. Interleukin-6 inhibits transforming growth factor-beta-induced apoptosis through the phosphatidylinositol 3-kinase/Akt and signal transducers and activators of transcription 3 pathways. J. Biol. Chem., 1999, 274, 23013-23019.
114. Ihle, J.N.; Witthuhn, B.A.; Quelle, F.W.; Yamamoto, K.; Thierfelder, W.E.; Kreider, B.;Silvennoinen, O. Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem. Sci., 1994, 19, 222-227. (Pubitemid 24187246)
115. Ishikawa, H.; Tsuyama, N.; Obata, M.;M, M.K. Mitogenic signals initiated via interleukin-6 receptor complexes in cooperation with other transmembrane molecules in myelomas. J. Clin. Exp. Hematop., 2006, 46, 55-66.
116. Yang, Y.M.; Han, C.Y.; Kim, Y.J.;Kim, S.G. AMPK-Associated signaling to bridge the gap between fuel metabolism and hepatocyte viability. World J. Gastroenterol., 2010, 16, 3731-3742.
117. Moreno-Aliaga, M.J.; Perez-Echarri, N.; Marcos-Gomez, B.; Larequi, E.; Gil-Bea, F.J.; Viollet, B.; Gimenez, I.; Martinez, J.A.; Prieto, J.;Bustos, M. Cardiotrophin-1 is a key regulator of glucose and lipid metabolism. Cell. Metab., 2011, 14, 242-253.
118. Wojtaszewski, J.F.; Jorgensen, S.B.; Hellsten, Y.; Hardie, D.G.;Richter, E.A. Glycogen-dependent effects of 5-Aminoimidazole-4-carboxamide (AICA)-riboside on AMP-Activated protein kinase and glycogen synthase activities in rat skeletal muscle. Diabetes, 2002, 51, 284-292. (Pubitemid 34764782)
119. Aggarwal, B.B.; Kunnumakkara, A.B.; Harikumar, K.B.; Gupta, S.R.; Tharakan, S.T.; Koca, C.; Dey, S.;Sung, B. Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship? Ann. N. Y. Acad. Sci., 2009, 1171, 59-76.
120. Pfitzner, E.; Kliem, S.; Baus, D.;Litterst, C.M. The role of STATs in inflammation and inflammatory diseases. Curr. Pharm. Des., 2004, 10, 2839-2850. (Pubitemid 39162402)
121. He-nan, Z.; Yan, W.; Miao-na, J.; Cai-hua, Z.; Shen, L.;Yu-jie, J. Relation of Cardiotrophin-1 (CT-1) and cardiac transcription factor GATA4 expression in rat's cardiac myocytes hypertrophy and apoptosis. Pathol. Res. Pract., 2009, 205, 615-625.
122. Freed, D.H.; Borowiec, A.M.; Angelovska, T.;Dixon, I.M. Induction of protein synthesis in cardiac fibroblasts by cardiotrophin-1: integration of multiple signaling pathways. Cardiovasc. Res., 2003, 60, 365-375. (Pubitemid 37412370)
123. Nakaoka, Y.; Nishida, K.; Fujio, Y.; Izumi, M.; Terai, K.; Oshima, Y.; Sugiyama, S.; Matsuda, S.; Koyasu, S.; Yamauchi-Takihara, K.; Hirano, T.; Kawase, I.;Hirota, H. Activation of gp130 transduces hypertrophic signal through interaction of scaffolding/docking protein Gab1 with tyrosine phosphatase SHP2 in cardiomyocytes. Circ. Res., 2003, 93, 221-229. (Pubitemid 36993233)
124. Pradervand, S.; Yasukawa, H.; Muller, O.G.; Kjekshus, H.; Nakamura, T.; St Amand, T.R.; Yajima, T.; Matsumura, K.; Duplain, H.; Iwatate, M.; Woodard, S.; Pedrazzini, T.; Ross, J.; Firsov, D.; Rossier, B.C.; Hoshijima, M.;Chien, K.R. Small proline-rich protein 1A is a gp130 pathway-And stress-inducible cardioprotective protein. EMBO. J., 2004, 23, 4517-4525. (Pubitemid 39601976)
125. Hagiwara, Y.; Miyoshi, S.; Fukuda, K.; Nishiyama, N.; Ikegami, Y.; Tanimoto, K.; Murata, M.; Takahashi, E.; Shimoda, K.; Hirano, T.; Mitamura, H.;Ogawa, S. SHP2-mediated signaling cascade through gp130 is essential for LIF-dependent I CaL, [Ca2+]i transient, and APD increase in cardiomyocytes. J. Mol. Cell. Cardiol., 2007, 43, 710-716. (Pubitemid 350166387)
126. Fujio, Y.; Nguyen, T.; Wencker, D.; Kitsis, R.N.;Walsh, K. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation, 2000, 101, 660-667. (Pubitemid 30094738)
127. Bhuiyan, M.S.;Fukunaga, K. Cardioprotection by vanadium compounds targeting Akt-mediated signaling. J. Pharmacol. Sci., 2009, 110, 1-13.
128. Negoro, S.; Oh, H.; Tone, E.; Kunisada, K.; Fujio, Y.; Walsh, K.; Kishimoto, T.;Yamauchi-Takihara, K. Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-kinase/Akt phosphorylation and Bcl-xL/caspase-3 interaction. Circulation, 2001, 103, 555-561. (Pubitemid 32116241)
129. Brar, B.K.; Stephanou, A.; Pennica, D.;Latchman, D.S. CT-1 mediated cardioprotection against ischaemic re-oxygenation injury is mediated by PI3 kinase, Akt and MEK1/2 pathways. Cytokine, 2001, 16, 93-96. (Pubitemid 34081702)
130. Lopez, N.; Varo, N.; Diez, J.;Fortuno, M.A. Loss of myocardial LIF receptor in experimental heart failure reduces cardiotrophin-1 cytoprotection. A role for neurohumoral agonists? Cardiovasc. Res., 2007, 75, 536-545. (Pubitemid 47080972)
131. Kuwahara, K.; Saito, Y.; Kishimoto, I.; Miyamoto, Y.; Harada, M.; Ogawa, E.; Hamanaka, I.; Kajiyama, N.; Takahashi, N.; Izumi, T.; Kawakami, R.;Nakao, K. Cardiotrophin-1 phosphorylates akt and BAD, and prolongs cell survival via a PI3K-dependent pathway in cardiac myocytes. J. Mol. Cell. Cardiol., 2000, 32, 1385-1394.
132. Hirota, H.; Chen, J.; Betz, U.A.; Rajewsky, K.; Gu, Y.; Ross, J., Jr.; Muller, W.;Chien, K.R. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell., 1999, 97, 189-198. (Pubitemid 29194270)
133. Fujio, Y.; Kunisada, K.; Hirota, H.; Yamauchi-Takihara, K.;Kishimoto, T. Signals through gp130 upregulate bcl-x gene expression via STAT1-binding cis-element in cardiac myocytes. J. Clin. Invest., 1997, 99, 2898-2905. (Pubitemid 27278666)
134. Bromberg, J.F.;Darnell, J.E., Jr. Potential roles of Stat1 and Stat3 in cellular transformation. Cold Spring Harb. Symp. Quant. Biol., 1999, 64, 425-428. (Pubitemid 30329307)
135. Bromberg, J.F.; Wrzeszczynska, M.H.; Devgan, G.; Zhao, Y.; Pestell, R.G.; Albanese, C.;Darnell, J.E., Jr. Stat3 as an oncogene. Cell., 1999, 98, 295-303. (Pubitemid 29380565)
136. Catlett-Falcone, R.; Landowski, T.H.; Oshiro, M.M.; Turkson, J.; Levitzki, A.; Savino, R.; Ciliberto, G.; Moscinski, L.; Fernandez-Luna, J.L.; Nunez, G.; Dalton, W.S.;Jove, R. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity, 1999, 10, 105-115. (Pubitemid 29077388)
137. Socolovsky, M.; Fallon, A.E.; Wang, S.; Brugnara, C.;Lodish, H.F. Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/-mice: a direct role for Stat5 in Bcl-X(L) induction. Cell., 1999, 98, 181-191.
138. Xuan, Y.T.; Guo, Y.; Han, H.; Zhu, Y.;Bolli, R. An essential role of the JAK-STAT pathway in ischemic preconditioning. Proc. Natl. Acad. Sci. U S A., 2001, 98, 9050-9055. (Pubitemid 32743867)
139. Dawn, B.; Xuan, Y.T.; Guo, Y.; Rezazadeh, A.; Stein, A.B.; Hunt, G.; Wu, W.J.; Tan, W.;Bolli, R. IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2. Cardiovasc. Res., 2004, 64, 61-71. (Pubitemid 39208923)
140. Xuan, Y.T.; Guo, Y.; Zhu, Y.; Han, H.; Langenbach, R.; Dawn, B.;Bolli, R. Mechanism of cyclooxygenase-2 upregulation in late preconditioning. J. Mol. Cell. Cardiol., 2003, 35, 525-537. (Pubitemid 36539458)
141. Xuan, Y.T.; Guo, Y.; Zhu, Y.; Wang, O.L.; Rokosh, G.; Messing, R.O.;Bolli, R. Role of the protein kinase C-epsilon-Raf-1-MEK-1/2-p44/42 MAPK signaling cascade in the activation of signal transducers and activators of transcription 1 and 3 and induction of cyclooxygenase-2 after ischemic preconditioning. Circulation, 2005, 112, 1971-1978. (Pubitemid 41377416)
142. Oshima, Y.; Fujio, Y.; Nakanishi, T.; Itoh, N.; Yamamoto, Y.; Negoro, S.; Tanaka, K.; Kishimoto, T.; Kawase, I.;Azuma, J. STAT3 mediates cardioprotection against ischemia/reperfusion injury through metallothionein induction in the heart. Cardiovasc. Res., 2005, 65, 428-435. (Pubitemid 40082485)
143. Zhao, Z.Q. Oxidative stress-elicited myocardial apoptosis during reperfusion. Curr. Opin. Pharmacol., 2004, 4, 159-165.
144. Kunisada, K.; Negoro, S.; Tone, E.; Funamoto, M.; Osugi, T.; Yamada, S.; Okabe, M.; Kishimoto, T.;Yamauchi-Takihara, K. Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy. Proc. Natl. Acad. Sci. U S A., 2000, 97, 315-319. (Pubitemid 30055828)
145. Stephanou, A.; Brar, B.; Heads, R.; Knight, R.D.; Marber, M.S.; Pennica, D.;Latchman, D.S. Cardiotrophin-1 induces heat shock protein accumulation in cultured cardiac cells and protects them from stressful stimuli. J. Mol. Cell. Cardiol., 1998, 30, 849-855. (Pubitemid 28190729)
146. Li, Y.J.; Cui, W.; Tian, Z.J.; Hao, Y.M.; Du, J.; Liu, F.; Zhang, H.; Zu, X.G.; Liu, S.Y.; Xie, R.Q.; Yang, X.H.; Wu, Y.Z.; Chen, L.;An, W. Crosstalk between ERK1/2 and STAT3 in the modulation of cardiomyocyte hypertrophy induced by cardiotrophin-1. Chin. Med. J. (Engl.), 2004, 117, 1135-1142. (Pubitemid 39199916)
147. Tian, Z.J.; Cui, W.; Li, Y.J.; Hao, Y.M.; Du, J.; Liu, F.; Zhang, H.; Zu, X.G.; Liu, S.Y.; Chen, L.;An, W. Different contributions of STAT3, ERK1/2, and PI3-K signaling to cardiomyocyte hypertrophy by cardiotrophin-1. Acta Pharmacol. Sin., 2004, 25, 1157-1164. (Pubitemid 39237407)
148. Takahashi, N.; Saito, Y.; Kuwahara, K.; Harada, M.; Tanimoto, K.; Nakagawa, Y.; Kawakami, R.; Nakanishi, M.; Yasuno, S.; Usami, S.; Yoshimura, A.;Nakao, K. Hypertrophic responses to cardiotrophin-1 are not mediated by STAT3, but via a MEK5-ERK5 pathway in cultured cardiomyocytes. J. Mol. Cel. Cardiol., 2005, 38, 185-192. (Pubitemid 40038665)
149. Tsuruda, T.; Jougasaki, M.; Boerrigter, G.; Huntley, B.K.; Chen, H.H.; D'Assoro, A.B.; Lee, S.C.; Larsen, A.M.; Cataliotti, A.;Burnett, J.C., Jr. Cardiotrophin-1 stimulation of cardiac fibroblast growth: roles for glycoprotein 130/leukemia inhibitory factor receptor and the endothelin type A receptor. Circ. Res., 2002, 90, 128-134. (Pubitemid 34627080)
150. Bluyssen, H.A.; Rastmanesh, M.M.; Tilburgs, C.; Jie, K.; Wesseling, S.; Goumans, M.J.; Boer, P.; Joles, J.A.;Braam, B. IFN gamma-dependent SOCS3 expression inhibits IL-6-induced STAT3 phosphorylation and differentially affects IL-6 mediated transcriptional responses in endothelial cells. Am. J. Physiol. Cell. Physiol., 2010, 299, C354-362.
151. Murray, P.J. The JAK-STAT signaling pathway: input and output integration. J. Immunol., 2007, 178, 2623-2629. (Pubitemid 46333135)
152. Terrell, A.M.; Crisostomo, P.R.; Wairiuko, G.M.; Wang, M.; Morrell, E.D.;Meldrum, D.R. Jak/STAT/SOCS signaling circuits and associated cytokine-mediated inflammation and hypertrophy in the heart. Shock, 2006, 26, 226-234.
153. Tanimoto, K.; Saito, Y.; Hamanaka, I.; Kuwahara, K.; Harada, M.; Takahashi, N.; Kawakami, R.; Nakagawa, Y.; Nakanishi, M.; Adachi, Y.; Shirakami, G.; Fukuda, K.; Yoshimura, A.;Nakao, K. SOCS1/JAB likely mediates the protective effect of cardiotrophin-1 against lipopolysaccharideinduced left ventricular dysfunction in vivo. Circ. J., 2005, 69, 1412-1417. (Pubitemid 41560824)
154. O'Shea, J.J.;Murray, P.J. Cytokine signaling modules in inflammatory responses. Immunity, 2008, 28, 477-487. (Pubitemid 351467044)
155. Leonard, M.O.; Hannan, K.; Burne, M.J.; Lappin, D.W.; Doran, P.; Coleman, P.; Stenson, C.; Taylor, C.T.; Daniels, F.; Godson, C.; Petasis, N.A.; Rabb, H.;Brady, H.R. 15-Epi-16-(para-fluorophenoxy)-lipoxin A(4)-methyl ester, a synthetic analogue of 15-epi-lipoxin A(4), is protective in experimental ischemic acute renal failure. J. Am. Soc. Nephrol., 2002, 13, 1657-1662. (Pubitemid 34579255)
156. Dittrich, A.; Khouri, C.; Sackett, S.D.; Ehlting, C.; Bohmer, O.; Albrecht, U.; Bode, J.G.; Trautwein, C.;Schaper, F. Glucocorticoids increase interleukin-6-dependent gene induction by interfering with the expression of the suppressor of cytokine signaling 3 feedback inhibitor. Hepatology, 2012, 55, 256-266.
157. Iniguez, M.; Dotor, J.; Feijoo, E.; Goni, S.; Prieto, J.; Berasain, C.;Avila, M.A. Novel pharmacologic strategies to protect the liver from ischemiareperfusion injury. Recent. Pat. Cardiovasc. Drug Discov., 2008, 3, 9-18. (Pubitemid 351211022)